Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.24    0.90 (2.70%)
Bid:
33.86
Ask:
35.30
Spread: 1.44 (4.253%)
Market Cap: £547.50m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Share buyback programme

1 Jun 2026 07:00

RNS Number : 2966G
Hays PLC
01 June 2026
Β 

Β 

Β 

Hays plc

Share buyback programme

Β 

1 June 2026

Hays plc ('Hays' or the 'Company') today announces a share buyback programme to purchase ordinary shares in the Company up to an aggregate consideration of Β£5 million (the 'Treasury Share Purchase Programme'). Shares purchased under the Treasury Share Purchase Programme will be held in treasury to ensure that the Company has sufficient treasury shares to satisfy its employee share plans.

The Company has entered into an agreement with BNP Paribas to conduct the Treasury Share Purchase Programme on its behalf during open periods. It is due to commence on 1 June 2026 and will conclude on or before 10 July 2026.

Β 

Notes

The maximum number of shares that may be purchased as part of the Treasury Share Purchase Programme shall not exceed the Company's existing authority obtained at its Annual General Meeting held on 19 November 2025 (the '2025 Authority') of 159,815,369, being the amount of the 2025 Authority not yet utilised as at the date of this announcement.Β 

The Treasury Share Purchase Programme will be conducted in accordance with (i) the 2025 Authority (ii) the assimilatedΒ UKΒ Market Abuse Regulation No. 596/2014 and assimilated Commission Delegated Regulation (EU) 2016/1052 (in each case as they form part of law of theΒ United KingdomΒ by virtue of the European Union (Withdrawal) Act 2018) (as amended) and (iii) Chapter 9 of theΒ UKΒ Financial Conduct Authority'sΒ UKΒ Listing Rules.

Β 

Enquiries

Hays plc

Rachel FordKean Marden

FGS Global Guy Lamming / Anjali Unnikrishnan / Richard Crowley

Β 

General Counsel & Company Secretary

Head of Investor Relations & M&A

Β 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

Β 

Β 

LEI: 213800QC8AWD4BO8TH08

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCSEDFDUEMSEDI
Date   Source Headline
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM
3rd Oct 202511:09 amRNSDirector/PDMR Shareholding
1st Oct 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.